Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1984 1
1985 1
1989 1
1990 1
1991 1
1993 1
1995 1
1996 1
1999 1
2000 1
2001 1
2002 1
2003 4
2004 8
2005 2
2006 1
2007 1
2008 4
2009 3
2010 5
2011 4
2012 7
2013 8
2014 5
2015 6
2016 9
2017 6
2018 4
2019 8
2020 6
2021 2
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.
Nyboe Andersen A, Nelson SM, Fauser BC, García-Velasco JA, Klein BM, Arce JC; ESTHER-1 study group. Nyboe Andersen A, et al. Fertil Steril. 2017 Feb;107(2):387-396.e4. doi: 10.1016/j.fertnstert.2016.10.033. Epub 2016 Nov 29. Fertil Steril. 2017. PMID: 27912901 Free article. Clinical Trial.
Demographic and medical consequences of the postponement of parenthood.
Schmidt L, Sobotka T, Bentzen JG, Nyboe Andersen A; ESHRE Reproduction and Society Task Force. Schmidt L, et al. Among authors: nyboe andersen a. Hum Reprod Update. 2012 Jan-Feb;18(1):29-43. doi: 10.1093/humupd/dmr040. Epub 2011 Oct 11. Hum Reprod Update. 2012. PMID: 21989171 Review.
Impact of letrozole co-treatment during ovarian stimulation with gonadotrophins for IVF: a multicentre, randomized, double-blinded placebo-controlled trial.
Bülow NS, Skouby SO, Warzecha AK, Udengaard H, Andersen CY, Holt MD, Grøndahl ML, Nyboe Andersen A, Sopa N, Mikkelsen ALE, Pinborg A, Macklon NS. Bülow NS, et al. Among authors: nyboe andersen a. Hum Reprod. 2022 Jan 28;37(2):309-321. doi: 10.1093/humrep/deab249. Hum Reprod. 2022. PMID: 34792133 Clinical Trial.
Can anti-Müllerian hormone concentrations be used to determine gonadotrophin dose and treatment protocol for ovarian stimulation?
Fleming R, Broekmans F, Calhaz-Jorge C, Dracea L, Alexander H, Nyboe Andersen A, Blockeel C, Jenkins J, Lunenfeld B, Platteau P, Smitz J, de Ziegler D. Fleming R, et al. Among authors: nyboe andersen a. Reprod Biomed Online. 2013 May;26(5):431-9. doi: 10.1016/j.rbmo.2012.02.027. Epub 2013 Feb 4. Reprod Biomed Online. 2013. PMID: 23507133 Review.
Anti-Müllerian hormone levels and fecundability in women with a natural conception.
Hvidman HW, Bang AK, Priskorn L, Scheike T, Birch Petersen K, Nordkap L, Loft A, Pinborg A, Tabor A, Jørgensen N, Nyboe Andersen A. Hvidman HW, et al. Among authors: nyboe andersen a. Eur J Obstet Gynecol Reprod Biol. 2017 Oct;217:44-52. doi: 10.1016/j.ejogrb.2017.08.015. Epub 2017 Aug 14. Eur J Obstet Gynecol Reprod Biol. 2017. PMID: 28846864
95 results